Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

DRI Healthcare Trust’s Expansion of its Royalty Entitlement on the U.S. Net Sales of Omidria®

February 01, 2024

On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.

The Cravath team is led by partner Daniel J. Cerqueira and includes foreign associate attorney Moritz Evertz on M&A matters; partners Nicholas A. Dorsey and Matthew M. Kelly and associate Tammuz Huberman on financing matters; partner David J. Kappos and of counsel Kathryn‑Ann Stamm on intellectual property matters; and partner Christopher K. Fargo, of counsel Kiran Sheffrin and associate Clayton Hackney on tax matters. Cierra Coury also worked on M&A matters and Matthew L. Ybarra also worked on intellectual property matters.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Capital Markets
  • Banking and Credit
  • Intellectual Property
  • Tax
  • Private Equity
  • Healthcare and Life Sciences
  • Financial Services and Insurance

People

Photo
Name
Daniel J. Cerqueira
Title
Corporate
Title
Partner
Email
dcerqueira@cravath.com
Phone
+1-212-474-1156
vCard
Download vCard

    Education

    • J.D., 2013, Harvard Law School
      magna cum laude
    • B.A., 2010, Cornell University
      Phi Beta Kappa

    Admitted In

    • New York
    Photo
    Name
    Nicholas A. Dorsey
    Title
    Corporate
    Title
    Partner
    Email
    ndorsey@cravath.com
    Phone
    +1-212-474-1764
    vCard
    Download vCard

      Education

      • J.D., 2009, Cornell Law School
        Order of the Coif, summa cum laude
      • M.Acc., 2006, Case Western Reserve University
        summa cum laude
      • B.S., 2006, Case Western Reserve University
        summa cum laude

      Admitted In

      • New York
      Photo
      Name
      Matthew M. Kelly
      Title
      Corporate
      Title
      Partner
      Email
      mkelly@cravath.com
      Phone
      +1-212-474-1318
      vCard
      Download vCard

        Education

        • J.D., 2013, New York University School of Law
          John Norton Pomeroy Scholar; Benjamin Butler Scholar; Order of the Coif, magna cum laude
        • A.B., 2006, Dartmouth College
          cum laude

        Admitted In

        • New York
        Photo
        Name
        David J. Kappos
        Title
        Corporate
        Title
        Partner
        Email
        dkappos@cravath.com
        Phone
        +1-212-474-1168
        vCard
        Download vCard

          Education

          • J.D., 1990, University of California, Berkeley, School of Law
          • B.S., 1983, University of California, Davis
            summa cum laude

          Admitted In

          • New York
          • California
          • District of Columbia
          Photo
          Name
          Christopher K. Fargo
          Title
          Tax
          Title
          Partner
          Email
          cfargo@cravath.com
          Phone
          +1-212-474-1236
          vCard
          Download vCard

            Education

            • J.D., 2006, Columbia Law School
              Harlan Fiske Stone; Michael Lynne Scholar
            • B.A., 2003, Boston College
              Honors Program, cum laude

            Admitted In

            • New York
            Photo
            Name
            Kathryn-Ann Stamm
            Title
            Corporate
            Title
            Of Counsel
            Email
            kstamm@cravath.com
            Phone
            +1-212-474-1979
            vCard
            Download vCard

              Education

              • J.D., 2016, Cornell Law School
              • LL.M., 2016, City University of Hong Kong
              • Master II, 2016, University Paris 1 Panthéon-Sorbonne
              • Master I, 2013, University Paris 1 Panthéon-Sorbonne
              • LL.B., 2013, University Paris 1 Panthéon-Sorbonne
              • LL.B., 2013, King's College London
                First Class Honors.

              Admitted In

              • New York
              Photo
              Name
              Kiran Sheffrin
              Title
              Tax
              Title
              Of Counsel
              Email
              ksheffrin@cravath.com
              Phone
              +1-212-474-1842
              vCard
              Download vCard

                Education

                • J.D., 2013, Brooklyn Law School
                  magna cum laude
                • B.A., 2010, Wesleyan University

                Admitted In

                • New York

                Related News & Insights

                Deals & Cases

                August 15, 2023

                DRI Healthcare Trust’s Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU®

                On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.

                Deals & Cases

                June 30, 2023

                DRI Healthcare Trust’s Acquisition of a Royalty Interest in Worldwide Net Sales of Orserdu™

                On June 30, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a royalty interest in the worldwide net sales of Orserdu™, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy, from Eisai Co., Ltd. for $85 million. In addition to the running royalties, DRI Healthcare Trust is also entitled to receive milestones based on the achievement of regulatory and sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.

                Deals & Cases

                April 27, 2023

                DRI Healthcare Trust’s Sale of its TZIELD™ Royalty Interest to Sanofi

                On April 27, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that its wholly‑owned subsidiary has sold its royalty interest and milestone payment obligations in the worldwide sales of TZIELD™, the first disease‑modifying treatment for the delay of Stage 3 type 1 diabetes, to Sanofi S.A. (“Sanofi”) for $210 million. Cravath represented DRI Capital Inc. in connection with the transaction.

                Cravath Bicentennial

                Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

                Explore

                Cravath, Swaine & Moore LLP Logo
                • CONTACT US
                • OUR STORY
                • ALUMNI PORTAL
                • DISCLAIMERS & NOTICES

                Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.